Chemours Company (the) · NYSE:CC

Chemours Company (the) — Q1 2026 Earnings Presentation

24 slides from Chemours Company (the)'s earnings presentation, May 6, 2026

  1. Slide 1: Q1 2026 Earnings Presentation

    Q1 2026 EARNINGS PRESENTATION May 5, 2026

  2. Slide 2: Safe Harbor Statement and Other Matters

    Safe Harbor Statement and Other Matters This presentation contains forward-looking statements, within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which involve risks and uncertainties. Forward-looking statements provide current exp

  3. Slide 3: First Quarter 2026 Highlights

    First Quarter 2026 Highlights Generated $1.4B in Net Sales and $169M in Adjusted EBITDA, supported by strong performance in the TSS and TT segments Achieved double-digit YoY Net Sales growth for Opteon Refrigerants driving first quarter records for TSS in both Net Sales and Adjusted EBITDA Announced

  4. Slide 4: First Quarter 2026 Financial Summary

    First Quarter 2026 Financial Summary ($ in millions unless otherwise noted; excludes per share amounts) 1Q26 1Q25 Y-o-Y ∆ 4Q25 Q-o-Q ∆ Net Sales $1,381 $1,368 $13 $1,329 $52 Net (Loss) / Income1 ($29) ($5) ($24) ($47) $18 Adj. Net Income 2 $8 $19 ($11) $7 $1 EPS 3 ($0.19) ($0.03) ($0.16) ($0.31) $0.

  5. Slide 5: Adjusted EBITDA Bridge: 1Q26 versus 1Q25

    Adjusted EBITDA Bridge: 1Q26 versus 1Q25 ($ in millions) ($16) $32 ($40) $27 $166 $169 1Q25 5 Price Volume Cost/Other Currency 1Q26 Price Impacts: $32 million due to higher pricing in TSS primarily driven by stronger Opteon Refrigerant blends mix paired with higher pricing associated with opportunis

  6. Slide 6: Quarterly Segment Summary

    Quarterly Segment Summary ($ in millions unless otherwise noted) Net Sales TSS TT APM $454 $466 $568 $591 $597 $559 $303 $294 $243 1Q24 1Q25 1Q26 1Q24 1Q25 1Q26 1Q24 1Q25 1Q26 Adjusted EBITDA and Margin (%) TSS TT APM $18 $150 $141 $190 $69 $50 $30 $32 $5 1Q24 1Q25 1Q26 1Q24 1Q25 1Q26 1Q24 1Q25 1Q26

  7. Slide 7: Liquidity Position as of March 31, 2026

    Liquidity Position as of March 31, 2026 ($ in millions unless otherwise noted) Total Liquidity 7 $1.5B Gross Debt $4.2B Net Debt 8 $3.6B TTM Net Leverage 9 4.9x $724 $54 Restricted $(44) $616 ($49) $53 Restricted ($15) $670 Unrestricted $563 Unrestricted 5 6 5 4Q25 Cash Balance Operating Cash Flows

  8. Slide 8: Strategic Progress

    STRATEGIC PROGRESS PATHWAY TO THRIVE

  9. Slide 9: Our Strategy

    Our Strategy PATHWAY TO THRIVE Operational Enabling Portfolio Strengthening Excellence Growth Management the Long-Term ❑Manufacturing excellence as a basis for success ❑Investing smartly in selected ❑Holistic portfolio analysis ❑Measurable progress on growth projects focused on distinct value resolv

  10. Slide 10: Progress Achieved to Date

    Progress Achieved to Date PATHWAY TO THRIVE Operational Enabling Portfolio Strengthening Excellence Growth Management the Long-Term ✓ Notable progress against the ✓ Continued double-digit YoY ✓ Progressed APM European asset ✓ Completed $700M 2034 senior $250M of run-rate savings by end quarterly gro

  11. Slide 11: Second Quarter Guidance

    Second Quarter GUIDANCE

  12. Slide 12: Second Quarter and Full Year 2026 Guidance

    Second Quarter and Full Year 2026 Guidance Sequential Business Outlook: Second Quarter 2026 Outlook Full Year 2026 Outlook  Consolidated o Net Sales: Expected to increase in the 15% to 20% range sequentially o Adjusted EBITDA: Expected to range between $220 million and $250 million, exclusive of po

  13. Slide 13: Appendix

    APPENDIX 13

  14. Slide 14: TSS Segment Net Sales and Adjusted EBITDA (Unaudited)

    TSS Segment Net Sales and Adjusted EBITDA (Unaudited) ($ in millions) ($ in millions) % of total Net Sales $568 FP&O $466 16% $41 FP&O $61 FreonTM 19% Refrigerants FreonTM 29% Refrig. 21% 1Q26 % total 1Q25 % total refrigerants: refrigerants: Freon = 34% OpteonTM OpteonTM Freon = 26% Opteon = $190 Re

  15. Slide 15: TT Segment Net Sales and Adjusted EBITDA (Unaudited)

    TT Segment Net Sales and Adjusted EBITDA (Unaudited) ($ in millions) ($ in millions) $597 Minerals 4% $559 $5 Minerals 3% $(43) TiO2 TiO2 96% 97% $50 $18 1Q25 Price/Currency Volume 1Q26 1Q25 Price/Currency Volume Cost/Other 1Q26 Net Sales: The decrease was primarily driven by a decrease in volumes g

  16. Slide 16: APM Segment Net Sales and Adjusted EBITDA (Unaudited)

    APM Segment Net Sales and Adjusted EBITDA (Unaudited) ($ in millions) ($ in millions) % of total Net Sales $294 $4 $243 Performance Solutions 41% ($55) Performance Solutions 39% Advanced $32 Materials Advanced 59% Materials 61% $5 1Q25 Price/Currency Volume 1Q25 1Q25 Price/Currency Volume Cost/Other

  17. Slide 17: Segment Net Sales (Unaudited)

    Segment Net Sales (Unaudited) 2024 2025 2026 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Net sales by product group and segment OpteonTM refrigerants $ 200 $ 227 $ 205 $ 178 $ 279 $ 375 $ 368 $ 243 $ 313 TM Freon refrigerants 173 173 146 124 97 123 98 113 162 Foam, propellants, and other 81 119 117 88 90 99 94 88 93

  18. Slide 18: Segment Net Sales by Region (Unaudited)

    Segment Net Sales by Region (Unaudited) 2024 2025 2026 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Net sales by geographic region North America: Thermal & Specialized Solutions $ 271 $ 308 $ 256 $ 194 $ 233 $ 336 $ 316 $ 241 $ 326 Titanium Technologies 246 274 270 236 267 282 252 221 235 Advanced Performance Materia

  19. Slide 19: Segment Net Sales and Adjusted EBITDA (Unaudited)

    Segment Net Sales and Adjusted EBITDA (Unaudited) 2024 2025 2026 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Segment Net Sales Thermal & Specialized Solutions $ 454 $ 519 $ 468 $ 390 $ 466 $ 597 $ 560 $ 444 $ 568 Titanium Technologies 592 676 672 632 597 657 612 561 559 Advanced Performance Materials 303 345 354 324

  20. Slide 20: GAAP Net Income to Adjusted Net Income and Adjusted EBITDA (Page 1/2)

    GAAP Net Income (Loss) Attributable to Chemours to Adjusted Net Income and Adjusted EBITDA Reconciliation (Unaudited) GAAP Net Leverage Ratio to Non-GAAP Net Leverage Ratio (Page 1/2) ($ in millions except per share amounts) Three Months Ended Three Months Ended Twelve Months Ended March 31, Decembe

  21. Slide 21: GAAP Net Income to Adjusted Net Income and Adjusted EBITDA (Page 2/2)

    GAAP Net Income (Loss) Attributable to Chemours to Adjusted Net Income and Adjusted EBITDA Reconciliation (Unaudited) GAAP Net Leverage Ratio to Non-GAAP Net Leverage Ratio (Page 2/2) ($ in millions except per share amounts) Three Months Ended Three Months Ended Twelve Months Ended March 31, Decembe

  22. Slide 22: GAAP Operating Cash Flow to Free Cash Flow Reconciliation

    GAAP Cash Flow Provided by Operating Activities to Free Cash Flows and Free Cash Flow Conversion Reconciliation Three Months Ended March 31, December 31, 2026 2025 2025 Cash flows (used for) provided by operating activities $ (44) $ (112) $ 137 Less: Purchases of property, plant, and equipment (49)

  23. Slide 23: 2026 Estimated GAAP Net Income to Estimated Adjusted EBITDA Reconciliation

    2026 Estimated GAAP Net Income Attributable to Chemours to Estimated Adjusted Net Income and Estimated Adjusted EBITDA Reconciliation; 2026 Estimated GAAP Cash Flow Provided by Operating Activities to Estimated Free Cash Flows and Estimated Free Cash Flow Conversion Reconciliation (Estimated) Year E

  24. Slide 24: © 2026 Chemours. All Rights Reserved

    ® 2026 CHEMOURS. ALL RIGHTS RESERVED​

Chemours Company (The) — Q1 2026 Earnings Presentation on 6ix